Kabuki syndrome: genes and variants
Explore variant evidence for Kabuki syndrome across 2 analyzed proteins (KMT2D, KDM6A). Linked ClinVar records include 48 pathogenic or likely pathogenic variants, 1,560 variants of uncertain significance and 398 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Kabuki syndrome
KMT2D: Histone-lysine N-methyltransferase 2D
It deposits enhancer-associated H3K4 methylation and coordinates developmental gene expression through chromatin regulatory complexes. Heterozygous loss-of-function variants are a major cause of Kabuki syndrome, and somatic mutations are common in several lymphomas and solid tumors.
34 ClinVar pathogenic / likely pathogenic and 1,602 uncertain variants in KMT2D have source records linked to Kabuki syndrome. Association strength is not clinical gene validity.
KDM6A: Lysine-specific demethylase 6A
It removes repressive H3K27 methylation and also contributes to chromatin regulation through demethylase-independent interactions. Germline loss-of-function variants cause Kabuki syndrome type 2, while somatic alterations occur in multiple cancers.
14 ClinVar pathogenic / likely pathogenic and 355 uncertain variants in KDM6A have source records linked to Kabuki syndrome. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): KMT2A.
Where Kabuki syndrome variants cluster
- KMT2D C2HC pre-PHD-type 2 (positions 5029–5069): 5 of 34 ClinVar pathogenic / likely pathogenic variants, 19.9× more than its size predicts (a length-based count, not a validated hotspot).
- KMT2D PHD-type 5 (positions 1427–1477): 4 of 34 ClinVar pathogenic / likely pathogenic variants, 12.8× more than its size predicts (a length-based count, not a validated hotspot).
- KMT2D SET (positions 5397–5513): 5 of 34 ClinVar pathogenic / likely pathogenic variants, 7.0× more than its size predicts (a length-based count, not a validated hotspot).
- KMT2D PHD-type 4 (positions 1377–1430): 3 of 34 ClinVar pathogenic / likely pathogenic variants, 9.1× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Kabuki syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| KDM6A Q1212R | 1212 | JmjC | Pathogenic / likely pathogenic (★★) |
| KDM6A R1255W | 1255 | JmjC | Pathogenic / likely pathogenic (★★) |
| KDM6A R1307W | 1307 | Pathogenic / likely pathogenic (★★) | |
| KDM6A Q1133R | 1133 | JmjC | Pathogenic / likely pathogenic (★★) |
| KMT2D H1453R | 1453 | PHD-type 5 | Pathogenic / likely pathogenic (★★) |
| KMT2D C1471W | 1471 | PHD-type 5 | Pathogenic / likely pathogenic (★★) |
| KMT2D R5340L | 5340 | WDR5 interaction motif (WIN) | Pathogenic / likely pathogenic (★★) |
| KMT2D E5425K | 5425 | SET | Pathogenic / likely pathogenic (★★) |
| KMT2D K4541R | 4541 | Pathogenic / likely pathogenic (★★) | |
| KMT2D W5065L | 5065 | C2HC pre-PHD-type 2 | Pathogenic / likely pathogenic (★) |
| KDM6A G1085R | 1085 | Interaction with SUPT6H | Pathogenic / likely pathogenic (★) |
| KDM6A C1153Y | 1153 | JmjC | Pathogenic / likely pathogenic (★) |
| KDM6A P1195L | 1195 | JmjC | Pathogenic / likely pathogenic (★) |
| KDM6A L1200F | 1200 | JmjC | Pathogenic / likely pathogenic (★) |
| KMT2D R3539G | 3539 | Pathogenic / likely pathogenic (★) | |
| KMT2D C5062S | 5062 | C2HC pre-PHD-type 2 | Pathogenic / likely pathogenic (★) |
| KMT2D R5179G | 5179 | FYR N-terminal | Pathogenic / likely pathogenic (★) |
| KMT2D R5179P | 5179 | FYR N-terminal | Pathogenic / likely pathogenic (★) |
| KMT2D A5413P | 5413 | SET | Pathogenic / likely pathogenic (★) |
| KMT2D A5413V | 5413 | SET | Pathogenic / likely pathogenic (★) |
| KMT2D S1476C | 1476 | PHD-type 5 | Pathogenic / likely pathogenic (★) |
| KDM6A G137C | 137 | TPR 2 | Pathogenic / likely pathogenic (★) |
| KDM6A A303D | 303 | TPR 6 | Pathogenic / likely pathogenic (★) |
| KDM6A V1228I | 1228 | JmjC | Pathogenic / likely pathogenic (★) |
| KMT2D C1380R | 1380 | PHD-type 4 | Pathogenic / likely pathogenic (★) |
| KMT2D R1423S | 1423 | PHD-type 4 | Pathogenic / likely pathogenic (★) |
| KMT2D C1430W | 1430 | PHD-type 5 | Pathogenic / likely pathogenic (★) |
| KMT2D E3004Q | 3004 | Pathogenic / likely pathogenic (★) | |
| KMT2D L3564F | 3564 | Coiled coil | Pathogenic / likely pathogenic (★) |
| KMT2D D5028H | 5028 | Pathogenic / likely pathogenic (★) | |
| KMT2D R5030L | 5030 | C2HC pre-PHD-type 2 | Pathogenic / likely pathogenic (★) |
| KMT2D C5035Y | 5035 | C2HC pre-PHD-type 2 | Pathogenic / likely pathogenic (★) |
| KMT2D C5133R | 5133 | PHD-type 7 | Pathogenic / likely pathogenic (★) |
| KMT2D C5230Y | 5230 | FYR N-terminal | Pathogenic / likely pathogenic (★) |
| KMT2D F5241L | 5241 | FYR C-terminal | Pathogenic / likely pathogenic (★) |
| KMT2D C5338Y | 5338 | WDR5 interaction motif (WIN) | Pathogenic / likely pathogenic (★) |
| KMT2D R5432L | 5432 | SET | Pathogenic / likely pathogenic (★) |
| KDM6A E47G | 47 | Interaction with SUPT6H | Pathogenic / likely pathogenic (★) |
| KMT2D R2001Q | 2001 | Pathogenic / likely pathogenic (★) | |
| KMT2D R3539W | 3539 | Pathogenic / likely pathogenic (★) | |
| KDM6A V1176I | 1176 | JmjC | Pathogenic / likely pathogenic (★) |
| KMT2D Q170H | 170 | PHD-type 1 | Pathogenic / likely pathogenic (★) |
| KMT2D R280K | 280 | RING-type 2 | Pathogenic / likely pathogenic (★) |
| KMT2D W5065S | 5065 | C2HC pre-PHD-type 2 | Pathogenic / likely pathogenic |
| KMT2D D2037H | 2037 | Pathogenic / likely pathogenic | |
| KMT2D C5104F | 5104 | PHD-type 7 | Pathogenic / likely pathogenic |
| KMT2D R5439P | 5439 | SET | Pathogenic / likely pathogenic |
| KDM6A S1025G | 1025 | Interaction with SUPT6H | Pathogenic / likely pathogenic |
Which prediction tools work for Kabuki syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 93 out of 100
- CATVariant: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 91 out of 100
- MutPred: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 83 out of 100
- MetaLR: 83 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 77 out of 100
Same protein, different disease
- Choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome also has ClinVar records linked to KMT2D variants; they fall partly in the same places as the Kabuki syndrome variants (6 pathogenic / likely pathogenic).
Diseases related to Kabuki syndrome
- Urinary bladder cancer, also linked to KDM6A and KMT2D
- Tremor, hereditary essential, also linked to KDM6A
- Choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome, also linked to KMT2D
- Medulloblastoma, also linked to KMT2D
- Head and neck squamous cell carcinoma, also linked to KMT2D
Frequently asked questions
Which genes have records linked to Kabuki syndrome?
This view contains 2 analyzed proteins: KMT2D, KDM6A. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 48 pathogenic or likely pathogenic variants, 1,560 variants of uncertain significance and 398 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 3,071 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center